106 related articles for article (PubMed ID: 8593091)
1. [Induction of antibiotic formation by inactive cultures of actinomycetes. A mutant strain of Streptomyces helvaticus, a new producer of bruneomycin].
Malkina ND; Dudnik IuV; Lysenkova LN; Terekhova LP; Katrukha GS
Antibiot Khimioter; 1995 Jun; 40(6):3-6. PubMed ID: 8593091
[TBL] [Abstract][Full Text] [Related]
2. [Induction of antibiotic production in inactive cultures of actinomycetes. Monensin production by a mutant strain 2608 EB-1].
Malkina ND; Lazhko EI; Lysenkova LN; Dudnik IuV
Antibiot Khimioter; 1995 Oct; 40(10):3-6. PubMed ID: 8660117
[TBL] [Abstract][Full Text] [Related]
3. [Rubomycin Q1--an anthracycline metabolite from Streptomyces coeruleorubidus 2679, a strain producing rubomycin C].
Fedorova GB; Golova TP; Arkhangel'skaia NM; Lazhko EI; Abramova EA; Bychkova OP; Polunin AD; Katrukha GS
Antibiot Khimioter; 1996 Mar; 41(3):3-8. PubMed ID: 8967800
[TBL] [Abstract][Full Text] [Related]
4. [Study of bruneomycin formed by Act. albus var. bruneomycini and its identification with streptonigrin].
Brazhnikova MG; Ponomarenko VI; Kovsharova IN; Krugliak EB; Proshliakova VV
Antibiotiki; 1968 Feb; 13(2):99-102. PubMed ID: 4970063
[No Abstract] [Full Text] [Related]
5. [Spontaneous and induced variability in Actinomyces rubiginosohelvolus, a new producer of the antibiotic rubomycin].
Lapchinskaia OA; Saburova TP; Siniagina OP; Konstantinova NV; Filicheva VA
Antibiotiki; 1975; 20(12):1061-5. PubMed ID: 1225178
[TBL] [Abstract][Full Text] [Related]
6. Novel cytocidal compounds, oxopropalines from Streptomyces sp. G324 producing lavendamycin. II. Physico-chemical properties and structure elucidations.
Abe N; Enoki N; Nakakita Y; Uchida H; Nakamura T; Munekata M
J Antibiot (Tokyo); 1993 Nov; 46(11):1678-86. PubMed ID: 8270489
[TBL] [Abstract][Full Text] [Related]
7. Epiderstatin, a new inhibitor of the mitogenic activity induced by epidermal growth factor. I. Taxonomy, fermentation, isolation and characterization.
Osada H; Sonoda T; Kusakabe H; Isono K
J Antibiot (Tokyo); 1989 Nov; 42(11):1599-606. PubMed ID: 2584144
[TBL] [Abstract][Full Text] [Related]
8. Anicemycin, a new inhibitor of anchorage-independent growth of tumor cells from Streptomyces sp. TP-A0648.
Igarashi Y; Ootsu K; Onaka H; Fujita T; Uehara Y; Furumai T
J Antibiot (Tokyo); 2005 May; 58(5):322-6. PubMed ID: 16060384
[TBL] [Abstract][Full Text] [Related]
9. [The antineoplastic antibiotic polypeptide 308 produced by Actinomadura recticatena. Its isolation and physicochemical properties].
Fedorova GB; Brazhnikova MG; Borisova VN; Tolstykh IV; Volkolupova OP
Antibiot Khimioter; 1988 Jun; 33(6):415-20. PubMed ID: 3421765
[TBL] [Abstract][Full Text] [Related]
10. [The isolation and characteristics of mutant Streptomyces globisporus 1912 defective for landomycin E biosynthesis].
Matseliukh BP; Lavrinchuk VIa
Mikrobiol Z; 1999; 61(4):22-7. PubMed ID: 10565147
[TBL] [Abstract][Full Text] [Related]
11. Induction of antibiotic production with ethidium bromide in Streptomyces hygroscopicus.
Ogura M; Tanaka T; Furihata K; Shimazu A; Otake N
J Antibiot (Tokyo); 1986 Oct; 39(10):1443-9. PubMed ID: 3781913
[TBL] [Abstract][Full Text] [Related]
12. [New anthracycline antibiotics taurimycins A and B produced by a Str. tauricus No. 7036-1 culture].
Frolova VI; Kuzovkov AD; Rozynov BV; Taĭg MM; Ivanitskaia LP
Antibiotiki; 1982 May; 27(5):326-31. PubMed ID: 6954874
[TBL] [Abstract][Full Text] [Related]
13. [Selection of a culture of Actinomyces coeruleorubidus, the producer of the antitumor antibiotic rubomycin].
Saburova TP; Lapchinskaia OA; Krugliak EB
Antibiotiki; 1974 Jun; 19(6):509-14. PubMed ID: 4849684
[No Abstract] [Full Text] [Related]
14. [Isolation and study of the antibiotics produced by a culture of Str. iverini (Gause et al., 1957) Pridham et al., 1958].
Frolova VI; Kuzovkov AD; Katrukha GS; Rozynov BV; Trifonova ZhP
Antibiotiki; 1984 Jan; 29(1):7-14. PubMed ID: 6696407
[TBL] [Abstract][Full Text] [Related]
15. Screening, isolation, taxonomy and fermentation of an antibiotic producer Streptomyces xinghaiensis from soil capable of acting against linezolid resistant strains.
Kumar KS; Anuradha S; Sarma GR; Venkateshwarlu Y; Kishan V
Indian J Exp Biol; 2012 Oct; 50(10):718-28. PubMed ID: 23214266
[TBL] [Abstract][Full Text] [Related]
16. A new pyrrolosesquiterpene isolated from cultures of Streptomyces sp.
Liu DZ; Liang BW
J Antibiot (Tokyo); 2014 May; 67(5):415-7. PubMed ID: 24549152
[TBL] [Abstract][Full Text] [Related]
17. [The effect of protoplast formation on the antibiotic activity and composition of the actinomycin complex in a strain of Streptomyces galbus (F) subsp. achromogenes 695 and in its active variants].
Iocheva LD; Antonova-Nikolova SK
Antibiot Khimioter; 2000; 45(4):10-3. PubMed ID: 10851643
[TBL] [Abstract][Full Text] [Related]
18. Isolation, purification and partial characterization of antibacterial activities produced by a newly isolated Streptomyces sp. US24 strain.
Mellouli L; Ben Ameur-Mehdi R; Sioud S; Salem M; Bejar S
Res Microbiol; 2003 Jun; 154(5):345-52. PubMed ID: 12837510
[TBL] [Abstract][Full Text] [Related]
19. Hybrid anthracyclines from a genetically engineered Streptomyces galilaeus mutant.
Kunnari TJ; Ylihonko KP; Klika KD; Mäntsälä PI; Hakala JM
J Org Chem; 2000 May; 65(10):2851-5. PubMed ID: 10814169
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of fusidic acid by resistant Streptomyces strains.
von der Haar B; Rosenberg D; Dittrich W; Schrempf H
J Antibiot (Tokyo); 1991 Jul; 44(7):785-92. PubMed ID: 1880068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
